MRPL21 promotes HCC proliferation through TP53 mutation-induced apoptotic resistance

CONCLUSION: Through its influence on TP53 mutation, MRPL21 promotes HCC proliferation and progression while conferring resistance to apoptosis. These findings suggest that MRPL21 holds promise as a valuable biomarker for the treatment of HCC.PMID:38181584 | DOI:10.1016/j.tice.2023.102298

Source: Tissue and Cell - January 5, 2024 Category: Cytology Authors: Tao Ma Ya-Bin Huang Jing Chen Lu Zhang Yan-Hua Liu Cui-Hua Lu Source Type: research